Triazoloamides as potent γ-secretase modulators with reduced hERG liability
摘要:
Synthesis and SAR studies of novel aryl triazoles as gamma secretase modulators (GSMs) are presented in this communication. Starting from our aryl triazole leads, optimization studies were continued and the series progressed towards novel amides and lactams. Triazole 57 was identified as the most potent analog in this series, displaying single-digit nanomolar A beta 42 IC50 in cell-based assays and reduced affinity for the hERG channel. (C) 2012 Elsevier Ltd. All rights reserved.
TRIAZOLE DERIVATIVES FOR TREATING ALZHEIMER'S DISEASE AND RELATED CONDITIONS
申请人:Fischer Christian
公开号:US20100222320A1
公开(公告)日:2010-09-02
Compounds of formula I: Selectively attenuate production of Aβ(1-42) and hence find use in treatment or prevention of diseases associated with deposition of Aβ in the brain, in particular Alzheimer's disease.